Category: Chronic Pulmonary Disorders

Chronic Pulmonary Disorders

Microneedle Patch for Peanut Allergies Begins Clinical Trials

A phase 1 study is testing the safety of a microneedle device designed to deliver peanut protein through the skin for desensitization.

Chronic Pulmonary Disorders

Cystic Fibrosis Care Still Below Pre-Pandemic Levels

New data shows that patient visits and lung function tests for cystic fibrosis have not returned to 2019 levels despite new treatments and telehealth options.

Chronic Pulmonary Disorders

CFTR Modulator Use Linked to Lower Anxiety in Children and Parents

New research suggests cystic fibrosis transmembrane conductance regulator (CFTR) modulators may provide mental health benefits for pediatric patients and their caregivers early in treatment.

Asthma

8 Recommendations for Asthma Patient Education

This article will provide 8 recommendations for effective patient education regarding inhaled medications used in treating/preventing asthma symptoms and flare-ups.

COPD

Nebulized Dual Bronchodilator Aero-007 Improved COPD Lung Function

AERO-007 demonstrated significant lung function improvements over 24 hours in patients with moderate-to-severe COPD.

Cystic fibrosis

Combination CF Drugs Formoterol + Methacholine May Improve Mucus Clearance

Combining formoterol and methacholine significantly improves mucociliary clearance in animal models of cystic fibrosis, compared to using either drug alone.

Pulmonary Fibrosis

Nebulized Treprostinil Preserved IPF Lung Function

Phase 3 trial results show significant reductions in clinical worsening and acute exacerbations for patients with idiopathic pulmonary fibrosis (IPF).

Allergies

Microplastics May Intensify Immune Response to Common Allergens

New research suggests that microplastic particles can bind to allergens and carry them deeper into the respiratory system.

Other Chronic Diseases

Hydroxyurea Reduced Mortality for Children With Sickle Cell Anemia

A 10-year study in sub-Saharan Africa revealed that a higher dose of the oral medication Hydroxyurea improved survival and growth outcomes in children with sickle cell anemia.